About Us Services Careers FAQ Contact Us 0
Home Pharmaceuticals Hydroxyzine Market Size To Surpass at a CAGR of 5.2% by 2032
Hydroxyzine Market

Hydroxyzine Market Size, Share & Trends Analysis Report By Dosage Form  (Tablets, Capsules, Injection, Syrup), By Indication Type  (Histamine-Mediated Pruritus, Urticaria, Atopic Contact Dermatoses) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Report Code: SRPH56078DR
Last Updated : May 06, 2024
Author : Straits Research
Starting From
USD 2300
Buy Now
File Formats

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Hydroxyzine Market Introduction
    2. By Dosage Form 
      1. Introduction
        1. Dosage Form  By Value
      2. Tablets
        1. By Value
      3. Capsules
        1. By Value
      4. Injection
        1. By Value
      5. Syrup
        1. By Value
    3. By Indication Type 
      1. Introduction
        1. Indication Type  By Value
      2. Histamine-Mediated Pruritus
        1. By Value
      3. Urticaria
        1. By Value
      4. Atopic Contact Dermatoses
        1. By Value
    1. Introduction
    2. By Dosage Form 
      1. Introduction
        1. Dosage Form  By Value
      2. Tablets
        1. By Value
      3. Capsules
        1. By Value
      4. Injection
        1. By Value
      5. Syrup
        1. By Value
    3. By Indication Type 
      1. Introduction
        1. Indication Type  By Value
      2. Histamine-Mediated Pruritus
        1. By Value
      3. Urticaria
        1. By Value
      4. Atopic Contact Dermatoses
        1. By Value
    4. U.S.
      1. By Dosage Form 
        1. Introduction
          1. Dosage Form  By Value
        2. Tablets
          1. By Value
        3. Capsules
          1. By Value
        4. Injection
          1. By Value
        5. Syrup
          1. By Value
      2. By Indication Type 
        1. Introduction
          1. Indication Type  By Value
        2. Histamine-Mediated Pruritus
          1. By Value
        3. Urticaria
          1. By Value
        4. Atopic Contact Dermatoses
          1. By Value
    5. Canada
    1. Introduction
    2. By Dosage Form 
      1. Introduction
        1. Dosage Form  By Value
      2. Tablets
        1. By Value
      3. Capsules
        1. By Value
      4. Injection
        1. By Value
      5. Syrup
        1. By Value
    3. By Indication Type 
      1. Introduction
        1. Indication Type  By Value
      2. Histamine-Mediated Pruritus
        1. By Value
      3. Urticaria
        1. By Value
      4. Atopic Contact Dermatoses
        1. By Value
    4. U.K.
      1. By Dosage Form 
        1. Introduction
          1. Dosage Form  By Value
        2. Tablets
          1. By Value
        3. Capsules
          1. By Value
        4. Injection
          1. By Value
        5. Syrup
          1. By Value
      2. By Indication Type 
        1. Introduction
          1. Indication Type  By Value
        2. Histamine-Mediated Pruritus
          1. By Value
        3. Urticaria
          1. By Value
        4. Atopic Contact Dermatoses
          1. By Value
    5. Germany
    6. France
    7. Spain
    8. Italy
    9. Russia
    10. Nordic
    11. Benelux
    12. Rest of Europe
    1. Introduction
    2. By Dosage Form 
      1. Introduction
        1. Dosage Form  By Value
      2. Tablets
        1. By Value
      3. Capsules
        1. By Value
      4. Injection
        1. By Value
      5. Syrup
        1. By Value
    3. By Indication Type 
      1. Introduction
        1. Indication Type  By Value
      2. Histamine-Mediated Pruritus
        1. By Value
      3. Urticaria
        1. By Value
      4. Atopic Contact Dermatoses
        1. By Value
    4. China
      1. By Dosage Form 
        1. Introduction
          1. Dosage Form  By Value
        2. Tablets
          1. By Value
        3. Capsules
          1. By Value
        4. Injection
          1. By Value
        5. Syrup
          1. By Value
      2. By Indication Type 
        1. Introduction
          1. Indication Type  By Value
        2. Histamine-Mediated Pruritus
          1. By Value
        3. Urticaria
          1. By Value
        4. Atopic Contact Dermatoses
          1. By Value
    5. Korea
    6. Japan
    7. India
    8. Australia
    9. Singapore
    10. Taiwan
    11. South East Asia
    12. Rest of Asia-Pacific
    1. Introduction
    2. By Dosage Form 
      1. Introduction
        1. Dosage Form  By Value
      2. Tablets
        1. By Value
      3. Capsules
        1. By Value
      4. Injection
        1. By Value
      5. Syrup
        1. By Value
    3. By Indication Type 
      1. Introduction
        1. Indication Type  By Value
      2. Histamine-Mediated Pruritus
        1. By Value
      3. Urticaria
        1. By Value
      4. Atopic Contact Dermatoses
        1. By Value
    4. UAE
      1. By Dosage Form 
        1. Introduction
          1. Dosage Form  By Value
        2. Tablets
          1. By Value
        3. Capsules
          1. By Value
        4. Injection
          1. By Value
        5. Syrup
          1. By Value
      2. By Indication Type 
        1. Introduction
          1. Indication Type  By Value
        2. Histamine-Mediated Pruritus
          1. By Value
        3. Urticaria
          1. By Value
        4. Atopic Contact Dermatoses
          1. By Value
    5. Turkey
    6. Saudi Arabia
    7. South Africa
    8. Egypt
    9. Nigeria
    10. Rest of MEA
    1. Introduction
    2. By Dosage Form 
      1. Introduction
        1. Dosage Form  By Value
      2. Tablets
        1. By Value
      3. Capsules
        1. By Value
      4. Injection
        1. By Value
      5. Syrup
        1. By Value
    3. By Indication Type 
      1. Introduction
        1. Indication Type  By Value
      2. Histamine-Mediated Pruritus
        1. By Value
      3. Urticaria
        1. By Value
      4. Atopic Contact Dermatoses
        1. By Value
    4. Brazil
      1. By Dosage Form 
        1. Introduction
          1. Dosage Form  By Value
        2. Tablets
          1. By Value
        3. Capsules
          1. By Value
        4. Injection
          1. By Value
        5. Syrup
          1. By Value
      2. By Indication Type 
        1. Introduction
          1. Indication Type  By Value
        2. Histamine-Mediated Pruritus
          1. By Value
        3. Urticaria
          1. By Value
        4. Atopic Contact Dermatoses
          1. By Value
    5. Mexico
    6. Argentina
    7. Chile
    8. Colombia
    9. Rest of LATAM
    1. Hydroxyzine Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Pfizer Inc.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. GlaxoSmithKline plc
    3. Teva Pharmaceutical Industries
    4. Piramal Healthcare UK Limited
    5. Alliance Pharma PLC
    6. Shanghai Ruizheng Chemical Technology Co. Ltd
    7. Lupin Pharmaceuticals Inc.
    8. OAK PHARMS INC.
    9. Changzhou ComWin Fine Chemicals Co. Ltd
    10. Novartis International AG
    11. Impax Laboratories Inc.
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer

Related Reports

Global Report
The hydroxychloroquine market size was valued at USD 1.02 billion in 2022. It is projected to reach USD 1.59 billion by 2031, growing at a CAGR of 5.10% during the forecast period (2023-2031).  A safe chloroquine derivative is hydroxychloroquin
Buy Now

Purchase Benefits

  • Eligible for a free updated report next year
  • Completely customizable scope
  • 30% discount on your next purchase
  • Dedicated account manager
  • Query resolution within 24 hours
  • Permission to print the report

We are featured on :

www.straitsresearch.com
© Copyright 2025. All rights Reserved.